hotspot -WSS

hotspot

author：comprehensive 2025-10-02 18:48:25 - browse：7622

Diversity in clinical trials concept — Adobe

The persistent lack of diversity among participants in clinical trials is a critical issue that is harming both populations that have long been left out of pivotal medical studies and the entire biomedical research enterprise, according to the authors of a report released Tuesday by the National Academies of Sciences, Engineering and Medicine.

Describing the need to move away from trials that focus largely on white men as “urgent,” the report’s authors called for a paradigm shift that gives less power to institutions that fund and conduct clinical research and more to communities under study. The sternly worded report said funding to include and recruit more diverse participants should be a priority that is enforced and said such investments could eventually lead to massive cost savings as the nation’s health disparities are reduced.

“An equitable clinical research enterprise would include trials and studies that match the demographics of the disease burden under study,” the report said. “However, we remain far from achieving this goal.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Beam Therapeutics to lay off 20% of its staff, re

hotspot

explore

WSS

Death of patient in Alzheimer’s trial raises question of possible risks

#NeedHerScience: shining a light on gender disparities in medicine

Cloning humans is technically possible. It's curious no one has tried

#NeedHerScience: shining a light on gender disparities in medicine

Senate committee scrutinizes Medicare Advantage brokers

Beam Therapeutics to lay off 20% of its staff, re

entertainment

hotspot

focus

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

New guidelines on severe brain injury complicate already difficult decisions

At least 13 dead in Texas as scorching temps continue

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

Bright Health sells Medicare Advantage business to Molina

The story of mRNA: From a loose idea to a tool that may help curb Covid

Medicare details structure of new drug price negotiation program

STAT Summit: GSK CEO on pharma giant's new direction

Anesthesiologist group: stop taking Ozempic before surgery

STAT Summit: Biotech founders on deal

knowledge

Why drug prescriptions should include diagnoses

How climate

STAT Summit: GSK CEO on pharma giant's new direction

Death of patient in Alzheimer’s trial raises question of possible risks

Senate committee scrutinizes Medicare Advantage brokers

Why health workers in Gaza are injured or die at high rates

hotspot

explore

knowledge

leisure time